mixed leukocyte reaction
Recently Published Documents


TOTAL DOCUMENTS

111
(FIVE YEARS 0)

H-INDEX

25
(FIVE YEARS 0)

2016 ◽  
Vol 64 (5) ◽  
pp. 409-416 ◽  
Author(s):  
Anna Korecka-Polak ◽  
Katarzyna Bocian ◽  
Maria Pachówka ◽  
Agnieszka Jałbrzykowska ◽  
Grażyna Korczak-Kowalska

2015 ◽  
Author(s):  
Erin Sult ◽  
Carl Hay ◽  
Qihui Huang ◽  
Stacy Fuhrmann ◽  
Robert Hollingsworth ◽  
...  

2015 ◽  
pp. 617-627
Author(s):  
Barbara Bain ◽  
L. Lowenstein ◽  
Shinpei Kasakura ◽  
Magdalene Vas

2015 ◽  
Vol 2015 ◽  
pp. 1-10
Author(s):  
Ewa Pocheć ◽  
Katarzyna Bocian ◽  
Marta Ząbczyńska ◽  
Grażyna Korczak-Kowalska ◽  
Anna Lityńska

N-glycosylation plays an important role in the majority of physiological and pathological processes occurring in the immune system. Alteration of the type and abundance of glycans is an element of lymphocyte differentiation; it is also common in the development of immune-mediated inflammatory diseases. The N-glycosylation process is very sensitive to different environmental agents, among them the pharmacological environment of immunosuppressive drugs. Some results show that high-mannose oligosaccharides have the ability to suppress different stages of the immune response. We evaluated the effects of cyclosporin A (CsA) and rapamycin (Rapa) on high-mannose/hybrid-type glycosylation in human leukocytes activated in a two-way mixed leukocyte reaction (MLR). CsA significantly reduced the number of leukocytes covered by high-mannose/hybrid N-glycans, and the synergistic action of CsA and Rapa led to an increase of these structures on the remaining leukocytes. This is the first study indicating thatβ1 andβ3 integrins bearing high-mannose/hybrid structures are affected by Rapa and CsA. Rapa taken separately and together with CsA changed the expression ofβ1 andβ3 integrins and, by regulating the protein amount, increased the oligomannose/hybrid-type N-glycosylation on the leukocyte surface. We suggest that the changes in the glycosylation profile of leukocytes may promote the development of tolerance in transplantation.


2014 ◽  
Vol 2014 ◽  
pp. 1-10 ◽  
Author(s):  
Mariana Pires Teixeira ◽  
Vivian Mary Rumjanek

Ouabain is a steroid capable of binding to and inhibiting Na+,-K+-ATPase. Studies have demonstrated some actions of ouabain on immune cells, which indicated both pro- and anti-inflammatory properties of this molecule. Nevertheless, its effects on human monocytes are still poorly understood. Thus, the present work investigated effects of ouabain in the activation and function of human adherent monocytes. Our results show that there is an increase in intracellular calcium levels already 5 minutes following monocyte treatment with 10−7 M of ouabain. Furthermore, monocytes expressed increased amounts of surface activation markers such as CD69, HLA-DR, CD86, and CD80 and also presented an augmented endocytic activity of dextran-FITC particles after 24 hours of culture in the presence of ouabain. However, monocytes treated with ouabain did not have an increased stimulatory capacity in allogeneic mixed leukocyte reaction. Ouabain-treated monocytes produced higher levels of IL-1βand TNF-αas reported before. A novel observation was the fact that ouabain induced IL-10 and VEGF as well. Collectively, these results suggest that ouabain impacts monocyte activation and modulates monocyte functions, implying that this steroid could act as an immunomodulator of these cells.


Author(s):  
JAN-AXEL AXELSSON ◽  
BENGT KÄLLÉN ◽  
OLLE NILSSON ◽  
GLAES TROPÉ

Blood ◽  
2009 ◽  
Vol 114 (1) ◽  
pp. 64-73 ◽  
Author(s):  
Hironori Matsushima ◽  
Hiroaki Tanaka ◽  
Norikatsu Mizumoto ◽  
Akira Takashima

Abstract By screening 720 natural compounds in a standard 2-way allogeneic mixed leukocyte reaction assay, we identified a potent immunosuppressive capacity of crassin acetate (CRA), a coral-derived cembrane diterpenoid. CRA efficiently inhibited allogeneic mixed leukocyte reaction as well as antigen-specific activation of CD4 T cells by bone marrow–derived dendritic cells (DCs). With regard to cellular targets, CRA suppressed not only mitogen-triggered T-cell activation, but also lipopolysaccharide-induced DC maturation, indicating dual functionality. Treatment with CRA at nontoxic doses induced heme oxygenase-1 (HO-1) mRNA/protein expression and HO-1 enzymatic activity in DCs, suggesting a unique mechanism of action. In fact, lipopolysaccharide-induced DC maturation was also inhibited by structurally unrelated compounds known to induce HO-1 expression or carbon monoxide (CO) release. Allergic contact hypersensitivity response to oxazolone and oxazolone-induced Langerhans cell migration from epidermis were both prevented almost completely by systemic administration of CRA. Not only do our results support the recent concept that HO-1/CO system negatively regulates immune responses, they also form both conceptual and technical frameworks for a more systematic, large-scale drug discovery effort to identify HO-1/CO-targeted immunosuppressants with dual target specificity.


Sign in / Sign up

Export Citation Format

Share Document